Scientech Research’s Zenas BioPharma ZBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBIO
Scientech Research's ZBIO Position: Q2 2026 in Review
Scientech Research reduced its Zenas BioPharma (ZBIO) stake by 30% in Q2 2026, selling an estimated $78K and leaving 9,028 shares worth $229K. The position accounts for 0.19% of the portfolio, ranked #144.
Scientech Research first reported a position in ZBIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $253K in Q1 2026. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.
- Scientech Research held 9,028 shares of Zenas BioPharma worth $229K as of Q2 2026.
- Scientech Research sold 3,924 Zenas BioPharma shares in Q2 2026, an estimated $78K.
- Zenas BioPharma made up 0.19% of Scientech Research's portfolio in Q2 2026, its #144 holding.
- Scientech Research first reported a position in Zenas BioPharma in Q1 2026 and has held it in 2 quarters since.
- Scientech Research's Zenas BioPharma position peaked at $253K in Q1 2026.
- 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.